Global Bladder Cancer Market Research Report 2023

The global Bladder Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Bladder Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Bladder Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Bladder Cancer in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Bladder Cancer include Bristol-Myers Squibb, Eli Lilly, F. Hoffman-La Roche, Pfizer, Accord Healthcare, AstraZeneca, Bedford Lab, Merck and Sanofi, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Bladder Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bladder Cancer.

The Bladder Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bladder Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bladder Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bladder Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Intravesical therapy

1.2.3 Chemotherapy

1.2.4 Preservation therapy

1.3 Market by Application

1.3.1 Global Bladder Cancer Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Bladder Cancer Market Perspective (2018-2029)

2.2 Bladder Cancer Growth Trends by Region

2.2.1 Global Bladder Cancer Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Bladder Cancer Historic Market Size by Region (2018-2023)

2.2.3 Bladder Cancer Forecasted Market Size by Region (2024-2029)

2.3 Bladder Cancer Market Dynamics

2.3.1 Bladder Cancer Industry Trends

2.3.2 Bladder Cancer Market Drivers

2.3.3 Bladder Cancer Market Challenges

2.3.4 Bladder Cancer Market Restraints

3.1 Global Top Bladder Cancer Players by Revenue

3.1.1 Global Top Bladder Cancer Players by Revenue (2018-2023)

3.1.2 Global Bladder Cancer Revenue Market Share by Players (2018-2023)

3.2 Global Bladder Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Bladder Cancer Revenue

3.4 Global Bladder Cancer Market Concentration Ratio

3.4.1 Global Bladder Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bladder Cancer Revenue in 2022

3.5 Bladder Cancer Key Players Head office and Area Served

3.6 Key Players Bladder Cancer Product Solution and Service

3.7 Date of Enter into Bladder Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Bladder Cancer Historic Market Size by Type (2018-2023)

4.2 Global Bladder Cancer Forecasted Market Size by Type (2024-2029)

5.1 Global Bladder Cancer Historic Market Size by Application (2018-2023)

5.2 Global Bladder Cancer Forecasted Market Size by Application (2024-2029)

6.1 North America Bladder Cancer Market Size (2018-2029)

6.2 North America Bladder Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Bladder Cancer Market Size by Country (2018-2023)

6.4 North America Bladder Cancer Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Bladder Cancer Market Size (2018-2029)

7.2 Europe Bladder Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Bladder Cancer Market Size by Country (2018-2023)

7.4 Europe Bladder Cancer Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Bladder Cancer Market Size (2018-2029)

8.2 Asia-Pacific Bladder Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Bladder Cancer Market Size by Region (2018-2023)

8.4 Asia-Pacific Bladder Cancer Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Bladder Cancer Market Size (2018-2029)

9.2 Latin America Bladder Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Bladder Cancer Market Size by Country (2018-2023)

9.4 Latin America Bladder Cancer Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Bladder Cancer Market Size (2018-2029)

10.2 Middle East & Africa Bladder Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Bladder Cancer Market Size by Country (2018-2023)

10.4 Middle East & Africa Bladder Cancer Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Detail

11.1.2 Bristol-Myers Squibb Business Overview

11.1.3 Bristol-Myers Squibb Bladder Cancer Introduction

11.1.4 Bristol-Myers Squibb Revenue in Bladder Cancer Business (2018-2023)

11.1.5 Bristol-Myers Squibb Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Detail

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Bladder Cancer Introduction

11.2.4 Eli Lilly Revenue in Bladder Cancer Business (2018-2023)

11.2.5 Eli Lilly Recent Development

11.3 F. Hoffman-La Roche

11.3.1 F. Hoffman-La Roche Company Detail

11.3.2 F. Hoffman-La Roche Business Overview

11.3.3 F. Hoffman-La Roche Bladder Cancer Introduction

11.3.4 F. Hoffman-La Roche Revenue in Bladder Cancer Business (2018-2023)

11.3.5 F. Hoffman-La Roche Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Detail

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Bladder Cancer Introduction

11.4.4 Pfizer Revenue in Bladder Cancer Business (2018-2023)

11.4.5 Pfizer Recent Development

11.5 Accord Healthcare

11.5.1 Accord Healthcare Company Detail

11.5.2 Accord Healthcare Business Overview

11.5.3 Accord Healthcare Bladder Cancer Introduction

11.5.4 Accord Healthcare Revenue in Bladder Cancer Business (2018-2023)

11.5.5 Accord Healthcare Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Detail

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Bladder Cancer Introduction

11.6.4 AstraZeneca Revenue in Bladder Cancer Business (2018-2023)

11.6.5 AstraZeneca Recent Development

11.7 Bedford Lab

11.7.1 Bedford Lab Company Detail

11.7.2 Bedford Lab Business Overview

11.7.3 Bedford Lab Bladder Cancer Introduction

11.7.4 Bedford Lab Revenue in Bladder Cancer Business (2018-2023)

11.7.5 Bedford Lab Recent Development

11.8 Merck

11.8.1 Merck Company Detail

11.8.2 Merck Business Overview

11.8.3 Merck Bladder Cancer Introduction

11.8.4 Merck Revenue in Bladder Cancer Business (2018-2023)

11.8.5 Merck Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Detail

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Bladder Cancer Introduction

11.9.4 Sanofi Revenue in Bladder Cancer Business (2018-2023)

11.9.5 Sanofi Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Bladder Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Intravesical therapy

    Table 3. Key Players of Chemotherapy

    Table 4. Key Players of Preservation therapy

    Table 5. Global Bladder Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Bladder Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Bladder Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Bladder Cancer Market Share by Region (2018-2023)

    Table 9. Global Bladder Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Bladder Cancer Market Share by Region (2024-2029)

    Table 11. Bladder Cancer Market Trends

    Table 12. Bladder Cancer Market Drivers

    Table 13. Bladder Cancer Market Challenges

    Table 14. Bladder Cancer Market Restraints

    Table 15. Global Bladder Cancer Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Bladder Cancer Market Share by Players (2018-2023)

    Table 17. Global Top Bladder Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bladder Cancer as of 2022)

    Table 18. Ranking of Global Top Bladder Cancer Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Bladder Cancer Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Bladder Cancer Product Solution and Service

    Table 22. Date of Enter into Bladder Cancer Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Bladder Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Bladder Cancer Revenue Market Share by Type (2018-2023)

    Table 26. Global Bladder Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Bladder Cancer Revenue Market Share by Type (2024-2029)

    Table 28. Global Bladder Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Bladder Cancer Revenue Market Share by Application (2018-2023)

    Table 30. Global Bladder Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Bladder Cancer Revenue Market Share by Application (2024-2029)

    Table 32. North America Bladder Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Bladder Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Bladder Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Bladder Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Bladder Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Bladder Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Bladder Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Bladder Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Bladder Cancer Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Bladder Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Bladder Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Bladder Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Bladder Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Bladder Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Bladder Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Bristol-Myers Squibb Company Detail

    Table 48. Bristol-Myers Squibb Business Overview

    Table 49. Bristol-Myers Squibb Bladder Cancer Product

    Table 50. Bristol-Myers Squibb Revenue in Bladder Cancer Business (2018-2023) & (US$ Million)

    Table 51. Bristol-Myers Squibb Recent Development

    Table 52. Eli Lilly Company Detail

    Table 53. Eli Lilly Business Overview

    Table 54. Eli Lilly Bladder Cancer Product

    Table 55. Eli Lilly Revenue in Bladder Cancer Business (2018-2023) & (US$ Million)

    Table 56. Eli Lilly Recent Development

    Table 57. F. Hoffman-La Roche Company Detail

    Table 58. F. Hoffman-La Roche Business Overview

    Table 59. F. Hoffman-La Roche Bladder Cancer Product

    Table 60. F. Hoffman-La Roche Revenue in Bladder Cancer Business (2018-2023) & (US$ Million)

    Table 61. F. Hoffman-La Roche Recent Development

    Table 62. Pfizer Company Detail

    Table 63. Pfizer Business Overview

    Table 64. Pfizer Bladder Cancer Product

    Table 65. Pfizer Revenue in Bladder Cancer Business (2018-2023) & (US$ Million)

    Table 66. Pfizer Recent Development

    Table 67. Accord Healthcare Company Detail

    Table 68. Accord Healthcare Business Overview

    Table 69. Accord Healthcare Bladder Cancer Product

    Table 70. Accord Healthcare Revenue in Bladder Cancer Business (2018-2023) & (US$ Million)

    Table 71. Accord Healthcare Recent Development

    Table 72. AstraZeneca Company Detail

    Table 73. AstraZeneca Business Overview

    Table 74. AstraZeneca Bladder Cancer Product

    Table 75. AstraZeneca Revenue in Bladder Cancer Business (2018-2023) & (US$ Million)

    Table 76. AstraZeneca Recent Development

    Table 77. Bedford Lab Company Detail

    Table 78. Bedford Lab Business Overview

    Table 79. Bedford Lab Bladder Cancer Product

    Table 80. Bedford Lab Revenue in Bladder Cancer Business (2018-2023) & (US$ Million)

    Table 81. Bedford Lab Recent Development

    Table 82. Merck Company Detail

    Table 83. Merck Business Overview

    Table 84. Merck Bladder Cancer Product

    Table 85. Merck Revenue in Bladder Cancer Business (2018-2023) & (US$ Million)

    Table 86. Merck Recent Development

    Table 87. Sanofi Company Detail

    Table 88. Sanofi Business Overview

    Table 89. Sanofi Bladder Cancer Product

    Table 90. Sanofi Revenue in Bladder Cancer Business (2018-2023) & (US$ Million)

    Table 91. Sanofi Recent Development

    Table 92. Research Programs/Design for This Report

    Table 93. Key Data Information from Secondary Sources

    Table 94. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Bladder Cancer Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Bladder Cancer Market Share by Type: 2022 VS 2029

    Figure 3. Intravesical therapy Features

    Figure 4. Chemotherapy Features

    Figure 5. Preservation therapy Features

    Figure 6. Global Bladder Cancer Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Bladder Cancer Market Share by Application: 2022 VS 2029

    Figure 8. Hospital Case Studies

    Figure 9. Clinic Case Studies

    Figure 10. Bladder Cancer Report Years Considered

    Figure 11. Global Bladder Cancer Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Bladder Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Bladder Cancer Market Share by Region: 2022 VS 2029

    Figure 14. Global Bladder Cancer Market Share by Players in 2022

    Figure 15. Global Top Bladder Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bladder Cancer as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Bladder Cancer Revenue in 2022

    Figure 17. North America Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Bladder Cancer Market Share by Country (2018-2029)

    Figure 19. United States Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Bladder Cancer Market Share by Country (2018-2029)

    Figure 23. Germany Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Bladder Cancer Market Share by Region (2018-2029)

    Figure 31. China Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Bladder Cancer Market Share by Country (2018-2029)

    Figure 39. Mexico Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Bladder Cancer Market Share by Country (2018-2029)

    Figure 43. Turkey Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Bristol-Myers Squibb Revenue Growth Rate in Bladder Cancer Business (2018-2023)

    Figure 46. Eli Lilly Revenue Growth Rate in Bladder Cancer Business (2018-2023)

    Figure 47. F. Hoffman-La Roche Revenue Growth Rate in Bladder Cancer Business (2018-2023)

    Figure 48. Pfizer Revenue Growth Rate in Bladder Cancer Business (2018-2023)

    Figure 49. Accord Healthcare Revenue Growth Rate in Bladder Cancer Business (2018-2023)

    Figure 50. AstraZeneca Revenue Growth Rate in Bladder Cancer Business (2018-2023)

    Figure 51. Bedford Lab Revenue Growth Rate in Bladder Cancer Business (2018-2023)

    Figure 52. Merck Revenue Growth Rate in Bladder Cancer Business (2018-2023)

    Figure 53. Sanofi Revenue Growth Rate in Bladder Cancer Business (2018-2023)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed